RO85245B1 - Procedeu de obtinere a serurilor hemotest oab - Google Patents

Procedeu de obtinere a serurilor hemotest oab

Info

Publication number
RO85245B1
RO85245B1 RO109251A RO10925182A RO85245B1 RO 85245 B1 RO85245 B1 RO 85245B1 RO 109251 A RO109251 A RO 109251A RO 10925182 A RO10925182 A RO 10925182A RO 85245 B1 RO85245 B1 RO 85245B1
Authority
RO
Romania
Prior art keywords
oab
preparing
blood test
test serums
serums
Prior art date
Application number
RO109251A
Other languages
English (en)
Romanian (ro)
Other versions
RO85245A2 (fr
Inventor
Maria Danielescu
Lauretia Onfriciuc
Maria Radulian
Silvia Elvira Elena Sirian
Maria Baclagian
Ecaterina Iacob
Ana Crohinov
Vlad Apateanu
Original Assignee
Centrul De Hematologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrul De Hematologie filed Critical Centrul De Hematologie
Priority to RO109251A priority Critical patent/RO85245B1/ro
Publication of RO85245A2 publication Critical patent/RO85245A2/fr
Publication of RO85245B1 publication Critical patent/RO85245B1/ro

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RO109251A 1982-12-08 1982-12-08 Procedeu de obtinere a serurilor hemotest oab RO85245B1 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO109251A RO85245B1 (ro) 1982-12-08 1982-12-08 Procedeu de obtinere a serurilor hemotest oab

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO109251A RO85245B1 (ro) 1982-12-08 1982-12-08 Procedeu de obtinere a serurilor hemotest oab

Publications (2)

Publication Number Publication Date
RO85245A2 RO85245A2 (fr) 1984-09-29
RO85245B1 true RO85245B1 (ro) 1984-10-30

Family

ID=20112331

Family Applications (1)

Application Number Title Priority Date Filing Date
RO109251A RO85245B1 (ro) 1982-12-08 1982-12-08 Procedeu de obtinere a serurilor hemotest oab

Country Status (1)

Country Link
RO (1) RO85245B1 (fr)

Also Published As

Publication number Publication date
RO85245A2 (fr) 1984-09-29

Similar Documents

Publication Publication Date Title
Pahwa et al. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes.
Andersson et al. K562—a human erythroleukemic cell line
McElrath et al. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections.
Lamon et al. The lymphocyte response to primary Moloney sarcoma virus tumors in BALB/c mice: definition of the active subpopulations at different times after infection
Perez et al. An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation
AU629180B2 (en) Antibody heteroconjugates for the killing of hiv infected cells
Matsushita et al. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.
ATE107353T1 (de) Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium.
Mathews et al. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
NO893373D0 (no) Et humant rhino-virus-reseptor-protein som hemmer virusinfeksjon.
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
Blumberg et al. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus
Shugars et al. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1
Oravecz et al. CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV–1 strains in a T–cell line
EP0022052A3 (fr) Procédé pour la séparation et l'isolement de la fraction AHF (facteur antihémophilique), la fraction fibronectine et la fraction Von Willebrand's ristocétine cofacteur à partir du plasma sanguin
Dutta-Roy et al. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets
Ruscetti et al. Persistent in vitro infection by human T‐cell leukemia‐lymphoma virus (HTLV) of normal human T‐lymphocytes from blood relatives of patients with HTLV‐associated mature T‐cell neoplasms
EP0179483A3 (en) Method for preparing monoclonal antibodies to hbsag
Mingari et al. Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones
Nour-Eldin et al. The blood clotting factors in human saliva
ES546974A0 (es) Un procedimiento de eliminacion del virus lav.
Biddison et al. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor
Praz et al. Alternative pathway of complement activation by human lymphoblastoid B and T cell lines.
Hardwicke et al. Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods